Option Care Health (NASDAQ:OPCH) Issues Earnings Results

Option Care Health (NASDAQ:OPCH) posted its quarterly earnings data on Wednesday. The company reported $0.30 earnings per share for the quarter, beating the consensus estimate of $0.27 by $0.03, Briefing.com reports. Option Care Health had a return on equity of 14.82% and a net margin of 4.60%. The company had revenue of $1.23 billion during the quarter, compared to analysts’ expectations of $1.17 billion. During the same period in the prior year, the business earned $0.63 earnings per share. Option Care Health’s revenue for the quarter was up 14.8% compared to the same quarter last year. Option Care Health updated its FY 2024 guidance to EPS.

Option Care Health Stock Up 2.7 %

Shares of OPCH stock traded up $0.84 during trading hours on Friday, hitting $31.61. 2,323,590 shares of the company were exchanged, compared to its average volume of 1,971,982. The business has a 50 day moving average of $29.10 and a two-hundred day moving average of $30.69. The company has a current ratio of 1.76, a quick ratio of 1.39 and a debt-to-equity ratio of 0.78. Option Care Health has a 52 week low of $26.11 and a 52 week high of $35.74. The company has a market capitalization of $5.41 billion, a PE ratio of 20.80, a PEG ratio of 2.33 and a beta of 1.24.

Analyst Upgrades and Downgrades

Several research analysts recently commented on the company. JMP Securities assumed coverage on Option Care Health in a research report on Tuesday, July 16th. They issued an “outperform” rating and a $36.00 target price for the company. Barrington Research raised their target price on Option Care Health from $38.00 to $40.00 and gave the stock an “outperform” rating in a research report on Thursday.

Option Care Health Company Profile

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.